Triple Slam (Almost)- Johnson and Johnson's JLABS, YCombinator, Stanford StartX
Dear Investors.
We are striving to be the most powerful insertable cardiac monitor company in the world to bring value to our patients and clinicians... and to solve a $21B problem.
As a startup, there is no other validation that is bigger than getting accepted to YCombinator, a premier funding of Billion dollar startups. But that's not all, we got accepted to Johnson and Johnson's JLABS before that. Rarely a startup gets to be both the JLABS and YC company.
However, there is one more that many are not aware of. And it is Stanford StartX - Many would consider StartX even more valuable than the YC.
We were very close last time as we made to the final rounds of interviews. Although we did not make the roster, we were placed on StartX Tracking mode. We are going at it again this time. They can't possible make the same mistake twice (haha).
Please take a look at the infographic and wish me luck!!
Thank you.